Detail Information
Publications
HMG-CoA reductase inhibitors and myotoxicityM Ucar
Division of Clinical Pharmacology, Norrland University Hospital, Umea, Sweden
Drug Saf 22:441-57. 2000..It is important that the potentially serious adverse reactions are recognised and correctly diagnosed so that the HMG-CoA reductase inhibitor may at once be withdrawn to prevent further muscular damage...
